CUVL

Clinuvel Pharmaceuticals Limited

Price Chart

No historical data available

Latest Quote

$6.16

-0.61 (-9.01%)

Current Price

Previous Close	$6.77
Open	$6.56
Day High	$6.56
Day Low	$6.12
Volume	51,250

Fetched: 2026-08-30T11:17:40

Stock Information

Note: Financial values converted from AUD to USD

Quarterly Dividend / Yield	$0.03 / 0.49%
Shares Outstanding	50.43M
Quarterly Dividend Yield	0.49%
Quarterly Dividend	$0.03
Total Debt	$1.39M
Cash Equivalents	$180.58M
Revenue	$67.36M
Net Income	$24.30M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$310.64M
P/E Ratio	14.67
EPS (TTM)	$0.42
Exchange	NMS

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. It is also developing NEURACTHEL (ACTH), an adrenocorticotropic hormone for targeting neurological, endocrinological, and degenerative disorders; SCENESSE and other formulations of afamelanotide to treat severe disorders, including vitiligo and porphyrias; and pharmaceutical formulations melanocortin technology for the treatment of a range of disorders. In addition, the company provides photocosmetic products for individuals and populations at risk of exposure to ultraviolet and high energy visible light, and in need of assistance in DNA repair and melanogenesis of the skin. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.

📰 Latest News

No news articles available at the moment. Check back later for updates on CUVL.

Period:

Income Statement (Annual)

Metric	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Revenue
Reconciled Cost Of Revenue	$11,393,490	$7,233,036	$6,306,156	$7,521,744
Cost Of Revenue	$11,393,490	$7,233,036	$6,306,156	$7,521,744
Total Revenue	$68,171,591	$63,264,673	$56,192,648	$47,153,313
Operating Revenue	$68,171,591	$63,264,673	$56,192,648	$47,153,313
Expenses
Interest Expense	$3,201,921	$3,195,790	$2,290,653	$1,631,767
Other Income Expense	$611,212	$-141,657	$547,483	$589,146
Other Non Operating Income Expenses	$611,212	$-141,657	$547,483	$589,146
Net Non Operating Interest Income Expense	$3,564,129	$2,059,534	$511,654	$-1,313,162
Interest Expense Non Operating	$3,201,921	$3,195,790	$2,290,653	$1,631,767
Operating Expense	$23,966,215	$21,589,223	$18,244,581	$14,283,566
Other Operating Expenses	$3,851,791	$2,814,994	$1,487,410	$1,032,408
General And Administrative Expense	$19,266,818	$17,954,652	$16,190,800	$12,707,445
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$25,952,443	$25,567,769	$21,957,644	$14,979,526
Net Interest Income	$3,564,129	$2,059,534	$511,654	$-1,313,162
Interest Income	$6,766,050	$5,255,324	$2,802,307	$318,605
Normalized Income	$25,952,443	$25,567,769	$21,957,644	$14,979,526
Net Income From Continuing And Discontinued Operation	$25,952,443	$25,567,769	$21,957,644	$14,979,526
Net Income Common Stockholders	$25,952,443	$25,567,769	$21,957,644	$14,979,526
Net Income	$25,952,443	$25,567,769	$21,957,644	$14,979,526
Net Income Including Noncontrolling Interests	$25,952,443	$25,567,769	$21,957,644	$14,979,526
Net Income Continuous Operations	$25,952,443	$25,567,769	$21,957,644	$14,979,526
Pretax Income	$36,987,227	$36,360,292	$32,701,047	$24,623,987
Interest Income Non Operating	$6,766,050	$5,255,324	$2,802,307	$318,605
Operating Income	$32,811,885	$34,442,415	$31,641,911	$25,348,003
Depreciation Amortization Depletion Income Statement	$847,606	$819,577	$566,371	$543,712
Depreciation And Amortization In Income Statement	$847,606	$819,577	$566,371	$543,712
Depreciation Income Statement	$847,606	$819,577	$566,371	$543,712
Gross Profit	$56,778,100	$56,031,638	$49,886,492	$39,631,568
Per Share
Diluted EPS	$0.52	$0.50	$0.42	$0.29
Basic EPS	$0.52	$0.51	$0.44	$0.30
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$41,036,754	$40,375,658	$35,558,072	$26,799,466
Reconciled Depreciation	$847,606	$819,577	$566,371	$543,712
EBITDA (Bullshit earnings)	$41,036,754	$40,375,658	$35,558,072	$26,799,466
EBIT	$40,189,148	$39,556,081	$34,991,701	$26,255,754
Diluted Average Shares	$36,145,465	$36,630,042	$37,153,374	$37,170,040
Basic Average Shares	$35,927,709	$35,754,076	$35,450,089	$35,450,089
Tax Provision	$11,034,783	$10,792,523	$10,743,404	$9,644,461
Selling General And Administration	$19,266,818	$17,954,652	$16,190,800	$12,707,445
Salaries And Wages	$19,266,818	$17,954,652	$16,190,800	$12,707,445

Fetched: 2026-08-23

Balance Sheet (Annual)

Metric	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Assets
Net Tangible Assets	$172,638,527	$145,520,392	$117,984,002	$89,951,215
Total Assets	$194,970,579	$165,822,595	$138,982,309	$103,278,467
Total Non Current Assets	$6,299,880	$6,500,005	$2,938,555	$2,415,679
Non Current Deferred Assets	$900,737	$732,059	$760,181	$345,530
Non Current Deferred Taxes Assets	$900,737	$732,059	$760,181	$345,530
Goodwill And Other Intangible Assets	$132,752	$132,752	$132,752	$132,752
Other Intangible Assets	$132,752	$132,752	-	-
Current Assets	$188,670,698	$159,322,590	$136,043,754	$100,862,787
Other Current Assets	$1,851,487	$954,557	-	-
Inventory	$6,328,979	$7,624,202	$6,829,862	$1,314,314
Receivables	$19,702,511	$18,825,007	$15,938,187	$11,624,290
Receivables Adjustments Allowances	$-109,742	$-107,265	$-119,212	-
Other Receivables	$2,364,396	$879,069	$1,128,494	$218,049
Accounts Receivable	$17,447,856	$18,053,203	$14,928,905	$11,406,241
Cash Cash Equivalents And Short Term Investments	$160,787,721	$131,918,825	$112,507,911	$87,178,414
Cash And Cash Equivalents	$160,787,721	$131,918,825	$112,507,911	$87,178,414
Cash Equivalents	$142,063,106	$118,929,490	$96,089,502	$70,784,309
Cash Financial	$18,724,616	$12,989,335	$16,418,408	$16,394,105
Prepaid Assets	-	-	$767,795	$745,769
Debt
Total Debt	$379,199	$631,212	$717,366	$901,515
Long Term Debt And Capital Lease Obligation	$69,841	$365,851	$501,522	$675,465
Current Debt And Capital Lease Obligation	$309,359	$265,362	$215,844	$226,050
Liabilities
Total Liabilities Net Minority Interest	$22,199,300	$20,169,451	$20,865,555	$13,194,499
Total Non Current Liabilities Net Minority Interest	$2,676,599	$2,080,633	$2,574,042	$3,342,152
Non Current Deferred Liabilities	$2,453,754	$1,597,147	$1,978,416	$2,593,830
Non Current Deferred Taxes Liabilities	$2,453,754	$1,597,147	$1,978,416	$2,593,830
Current Liabilities	$19,522,701	$18,088,818	$18,291,513	$9,852,347
Current Deferred Liabilities	$10,436,959	$11,372,782	$11,546,977	$5,222,735
Current Deferred Taxes Liabilities	$10,436,959	$11,372,782	$11,546,977	$5,222,735
Payables And Accrued Expenses	$7,134,864	$5,100,482	$5,488,285	$2,351,741
Payables	$7,134,864	$5,100,482	$5,488,285	$2,351,741
Other Payable	$5,304,905	$3,417,719	$3,485,364	$2,165,775
Accounts Payable	$1,829,959	$1,682,764	$2,002,921	$185,966
Equity
Common Stock Equity	$172,771,279	$145,653,144	$118,116,754	$90,083,968
Total Equity Gross Minority Interest	$172,771,279	$145,653,144	$118,116,754	$90,083,968
Stockholders Equity	$172,771,279	$145,653,144	$118,116,754	$90,083,968
Gains Losses Not Affecting Retained Earnings	$5,664,967	$3,045,897	$16,183,127	$8,689,981
Other Equity Adjustments	$1,771,832	-	$13,897,291	$7,447,451
Retained Earnings	$45,653,696	$21,497,794	$-7,012,681	$-27,552,321
Other
Ordinary Shares Number	$35,961,850	$35,928,954	$35,450,089	$35,450,089
Share Issued	$35,961,850	$35,928,954	$35,450,089	$35,450,089
Tangible Book Value	$172,638,527	$145,520,392	$117,984,002	$89,951,215
Invested Capital	$172,771,279	$145,653,144	$118,116,754	$90,083,968
Working Capital	$169,147,998	$141,233,772	$117,752,241	$91,010,441
Capital Lease Obligations	$379,199	$631,212	$717,366	$901,515
Total Capitalization	$172,771,279	$145,653,144	$118,116,754	$90,083,968
Foreign Currency Translation Adjustments	$3,893,136	$3,045,897	$2,285,836	$1,242,530
Capital Stock	$121,452,616	$121,109,453	$108,946,308	$108,946,308
Common Stock	$121,452,616	$121,109,453	$108,946,308	$108,946,308
Employee Benefits	$91,682	$60,784	$40,589	$22,703
Non Current Pension And Other Postretirement Benefit Plans	$91,682	$60,784	$40,589	$22,703
Long Term Capital Lease Obligation	$69,841	$365,851	$501,522	$675,465
Long Term Provisions	$61,322	$56,850	$53,515	$50,154
Current Capital Lease Obligation	$309,359	$265,362	$215,844	$226,050
Pensionand Other Post Retirement Benefit Plans Current	$1,641,519	$1,350,192	$1,040,407	$2,051,821
Investments And Advances	$153,064	$96,289	-	-
Other Investments	$153,064	$96,289	-	-
Net PPE	$5,113,327	$5,538,904	$2,045,621	$1,937,397
Accumulated Depreciation	$-2,744,655	$-2,108,925	$-1,688,046	$-1,191,238
Gross PPE	$7,857,982	$7,647,829	$3,733,667	$3,128,635
Leases	$1,425,599	$1,425,599	$1,354,605	$899,249
Other Properties	$1,332,827	$1,330,860	$1,311,916	$1,304,225
Machinery Furniture Equipment	$1,500,929	$1,327,180	$1,067,146	$925,161
Land And Improvements	$3,598,627	$3,564,190	-	-
Finished Goods	$2,127,174	$2,172,915	$1,140,701	$212,357
Work In Process	$3,711,177	$5,041,494	$5,356,863	$843,899
Raw Materials	$490,627	$409,793	$369,359	$372,645
Goodwill	-	-	$132,752	$132,752
Inventories Adjustments Allowances	-	-	$-37,061	$-114,587

Fetched: 2026-08-23

Cash Flow Statement (Annual)

Metric	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Free Cash Flow
Free Cash Flow	$29,270,264	$22,584,061	$25,745,823	$28,295,194
Operating Activities
Cash Flowsfromusedin Operating Activities Direct	$29,484,475	$26,584,789	$26,483,039	$28,606,887
Classesof Cash Receiptsfrom Operating Activities	$67,311,439	$60,678,662	$53,737,784	$47,795,076
Other Cash Receiptsfrom Operating Activities	$1	$149,658	-	-
Investing Activities
Capital Expenditure	$-214,211	$-4,000,728	$-737,216	$-311,693
Investing Cash Flow	$-34,234,561	$-20,830,768	$-737,216	$-311,693
Cash Flow From Continuing Investing Activities	$-34,234,561	$-20,830,768	$-737,216	$-311,693
Financing Activities
Repurchase Of Capital Stock	$-316,334	$-3,522,202	-	-
Issuance Of Capital Stock	$135,601	$2,981,066	-	-
Financing Cash Flow	$-2,108,355	$-2,562,639	$-1,607,212	$-1,078,890
Cash Flow From Continuing Financing Activities	$-2,108,355	$-2,562,639	$-1,607,212	$-1,078,890
Net Other Financing Charges	$-131,081	$-498,413	$-378,416	$-385,266
Cash Dividends Paid	$-1,796,541	$-1,772,296	$-1,418,004	$-886,257
Common Stock Dividend Paid	$-1,796,541	$-1,772,296	$-1,418,004	$-886,257
Net Common Stock Issuance	$-180,733	$-541,136	-	-
Common Stock Issuance	$135,601	$2,981,066	-	-
Other
Income Tax Paid Supplemental Data	$11,282,679	$11,226,941	$5,556,695	-
End Cash Position	$20,103,783	$25,255,236	$112,507,911	$87,178,414
Beginning Cash Position	$25,255,236	$22,882,063	$87,178,414	$59,327,720
Effect Of Exchange Rate Changes	$1,706,988	$-818,208	$1,190,885	$634,390
Changes In Cash	$-6,858,441	$3,191,382	$24,138,611	$27,216,304
Common Stock Payments	$-316,334	$-3,522,202	-	-
Net Investment Purchase And Sale	$-34,020,350	$-16,830,040	-	-
Purchase Of Investment	$-34,020,350	$-16,830,040	-	-
Net PPE Purchase And Sale	$-214,211	$-4,000,728	$-737,216	$-311,693
Purchase Of PPE	$-214,211	$-4,000,728	$-737,216	$-311,693
Taxes Refund Paid Direct	$-11,282,679	$-11,051,774	$-5,369,492	$257,345
Interest Received Direct	$5,345,324	$5,476,428	$1,956,612	$178,648
Classesof Cash Payments	$-31,889,609	$-28,518,526	$-23,841,864	$-19,624,181
Paymentsto Suppliersfor Goodsand Services	$-31,889,609	$-28,518,526	$-23,841,864	$-19,624,181
Receiptsfrom Government Grants	$17,350	$247,090	$15,791	$155,875
Receiptsfrom Customers	$67,294,087	$60,281,914	$53,721,994	$47,639,202

Fetched: 2026-08-23